120 related articles for article (PubMed ID: 3872100)
41. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
42. [Methods of determining circulating immune complexes].
Baleva M
Vutr Boles; 1983; 22(6):1-5. PubMed ID: 6369791
[No Abstract] [Full Text] [Related]
43. The role of circulating immune complexes in the aetiology of polymorphic eruption of pregnancy.
Kasp-Grochowska E; Beck J; Holmes RC; Black MM; Timlin D
Arch Dermatol Res; 1984; 276(2):71-3. PubMed ID: 6232902
[TBL] [Abstract][Full Text] [Related]
44. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
45. IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes.
Herrmann D; Jäger L; Hein G; Henzgen M; Schlenvoigt G
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):302-7. PubMed ID: 1669588
[TBL] [Abstract][Full Text] [Related]
46. Circulating immune complexes in human acute leukaemia.
Balestrieri G; Tincani A; Cattaneo R; Rossi G; Verzura P; Marini G; Calculli G; Ferremi P; Marinone G
Br J Haematol; 1981 Oct; 49(2):269-74. PubMed ID: 6975116
[TBL] [Abstract][Full Text] [Related]
47. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis.
Zlabinger GJ; Haberhauer G; Dax K; Menzel EJ; Bröll H
Clin Exp Rheumatol; 1990; 8(2):113-9. PubMed ID: 2338008
[TBL] [Abstract][Full Text] [Related]
48. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
[TBL] [Abstract][Full Text] [Related]
49. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
50. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
[TBL] [Abstract][Full Text] [Related]
51. [The liquid phase C1q binding assay and its clinical application].
Cheng PZ; Dong Y; Zhang NZ; Ji D; Dai X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
[No Abstract] [Full Text] [Related]
52. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
53. Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC).
Migliorini P; Aiuti F; Balestrieri G; Bombardieri S; Cantarella S; Carbonara A; Clerici E; Coppo R; Cordiali Fei P; D'Amelio R
Clin Immunol Immunopathol; 1984 Sep; 32(3):298-315. PubMed ID: 6235997
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
55. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
56. Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity for rheumatoid arthritis.
McDougal JS; Hubbard M; McDuffie FC; Strobel PL; Smith SJ; Bass N; Goldman JA; Hartman S; Myerson G; Miller S; Morales R; Wilson CH
Arthritis Rheum; 1982 Oct; 25(10):1156-66. PubMed ID: 6753850
[TBL] [Abstract][Full Text] [Related]
57. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
58. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
Bratt T; Ohlson S
J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
[TBL] [Abstract][Full Text] [Related]
59. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
[TBL] [Abstract][Full Text] [Related]
60. Circulating immune complexes in patients with rheumatoid arthritis: correlation with disease activity.
Levo Y; Fischel R; Ehrenfeld M
J Rheumatol; 1981; 8(5):851-5. PubMed ID: 7310781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
